Bunkerhill Health

bunkerhillhealth.com

-65%

est. 2Y upside i

HealthcareAI & MLSeries A

Bunkerhill Health is building the system of action for health systems

Rank

#2036

Sector

Healthcare Technology, Artificial Intelligence

Est. Liquidity

~5Y

Data Quality

Data: Medium

Bunkerhill Health presents a moderate upside opportunity for a job seeker, driven by its strong competitive moat from FDA-cleared AI and significant customer traction in a large, growing market.

Last updated: March 10, 2026

Bull (20%)+300%

Bunkerhill Health successfully expands its Carebricks platform across major health systems, leveraging its FDA clearances and strong integrations to capture significant market share from incumbents. Revenue scales to over $100M by 2028, justifying a $480M+ valuation at a premium multiple due to its defensible moat and critical role in healthcare AI.

Base (40%)+50%

Bunkerhill Health continues to grow steadily, securing additional customer wins and expanding its platform's capabilities. It maintains its niche but faces ongoing competition from incumbents, leading to a more modest growth trajectory. Revenue reaches ~$30M by 2028, resulting in an exit valuation of approximately $180M.

Bear (40%)-80%

Dominant EHR vendors or large tech companies with vast resources introduce directly competing solutions, commoditizing Bunkerhill's offerings or significantly slowing its sales cycle. Growth stalls, and the company struggles to raise subsequent funding rounds at a favorable valuation, leading to a down round or acquisition at ~$24M, wiping out most common stock value.

Est. time to liquidity~5.0 years

Preference Stack Risk

high

Investors hold $30M in liquidation preferences ahead of common shareholders. In an exit at or below $30M, common shareholders would receive little to nothing.

Dilution Risk

high

As a Series A company, Bunkerhill Health will likely require multiple additional funding rounds, leading to further dilution for existing equity holders.

Secondary Liquidity

none

Given its Series A stage, there is currently no active secondary market or tender offers for Bunkerhill Health's equity.

Operations 2 roles

All 1 role

Engineering 1 role

View all 4 open roles at Bunkerhill Health

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Bunkerhill Health's data — designed to show you've done your homework.

  • 1

    Given the high incumbent threat from major EHR vendors and large tech companies, what is Bunkerhill Health's long-term strategy to maintain and expand its competitive moat beyond current FDA clearances and integrations?

  • 2

    With current revenue around $4M and a large TAM, what are the key milestones and growth levers the company is focused on to scale revenue significantly over the next 2-3 years, and how will profitability be managed?

  • 3

    Considering the Series A funding and the need for future capital, how does Bunkerhill Health plan to manage potential dilution for employees, and what is the anticipated timeline for a liquidity event?

Community

Valuation Sentiment

Our model estimates -65% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.